Deviation – Page 44 – Pharma.Tips

Batch executed with expired SOP during inspection preparation – CAPA ineffectiveness identified

Addressing GMP Deviations: The Case of a Batch Executed with Expired SOP During Inspection Preparation In pharmaceutical manufacturing, maintaining compliance with Good Manufacturing Practices (GMP) is critical to ensuring product…

Unapproved process parameter change during commercial campaign – regulatory impact assessment case study

Case Study: Assessing the Impact of Unapproved Process Parameter Changes in a Commercial Environment In the highly regulated landscape of pharmaceutical manufacturing, adherence to established protocols is crucial for maintaining…

Critical IPC skipped during changeover – CAPA ineffectiveness identified

Investigation of a Critical IPC Omission During Changeover: A Case Study In the fast-paced environment of pharmaceutical manufacturing, ensuring compliance with Good Manufacturing Practices (GMP) is paramount. However, lapses can…

Critical IPC skipped during scale-up – regulatory impact assessment case study

Assessing the Regulatory Impact of Skipped Critical IPCs During Scale-Up In pharmaceutical manufacturing, ensuring the integrity of every process step is vital. A recent case study highlights a significant deviation…

Unplanned hold time extension during scale-up – CAPA ineffectiveness identified

Addressing Unplanned Hold Time Extensions in Pharmaceutical Scale-Up Processes Unplanned hold time extensions during the scale-up of pharmaceutical manufacturing processes can lead to significant regulatory challenges and product quality concerns.…

CCIT failure during packaging – regulatory risk assessment

Regulatory Risk Assessment of CCIT Failures During Packaging In the fast-paced world of pharmaceutical manufacturing, the failure of container closure integrity testing (CCIT) during the packaging process can pose significant…

Viscosity variation during storage – QA investigation failure

Investigation of Viscosity Variations During Storage in Pharmaceuticals Viscosity variation during storage is a frequent issue observed in pharmaceutical manufacturing, particularly with suspensions and syrups. Such nonconformance can prompt Out…

Phase separation after temperature excursion – QA investigation failure

Investigating Phase Separation After Temperature Excursion: A Comprehensive QA Approach In the world of pharmaceutical manufacturing, deviations from established protocols can lead to significant quality concerns and product failures. One…

Tube leakage after packaging change – inspection readiness risk

Investigating Tube Leakage Issues Following Packaging Change: Ensuring Inspection Readiness In the fast-paced world of pharmaceutical manufacturing, packaging changes are a common necessity. However, they can also introduce significant risks,…

pH drift on storage at accelerated conditions – stability investigation failure

Stability Investigation of pH Drift During Storage at Accelerated Conditions Issues related to pH drift during storage at accelerated conditions represent significant risks in pharmaceutical manufacturing. Such deviations can result…

Physical appearance change during shelf-life extension – stability investigation failure

Stability Investigation Failures: Addressing Physical Appearance Changes During Shelf-Life Extension The occurrence of physical appearance changes during the shelf-life extension of pharmaceutical products can indicate underlying issues that may lead…

Impurity increase during shelf-life extension – CAPA and shelf-life justification gap

Addressing Increased Impurities in Extended Product Shelf-Life: A Comprehensive Investigation Guide In the pharmaceutical manufacturing landscape, the integrity of product quality during shelf-life extension poses significant challenges. An increase in…